New Clinical Guideline for Arthritis Pain
The American Pain Society (APS), the leading US professional organization devoted to pain management, recently released the first evidence-based, multidisciplinary guideline for treating acute and chronic arthritis pain.
The full text of the APS guideline is available at
Recommendations:
? For mild-to-moderate pain?acet-aminophen is the drug of choice because of its mild side effects, wide availability, and low cost.
? For moderate-to-severe pain?cyclooxygenase-2 (COX-2) non-steroidal anti-inflammatory drugs (NSAIDs), such as Celebrex and Vioxx, are the drugs of choice for their pain-relieving potency and absence of gastrointestinal (GI) side effects.
? If the patient fails to respond to acetaminophen and COX-2 drugs, nonselective NSAIDs should be considered, but only if the patient is not at risk for NSAID-induced GI side effects.
? For severe arthritis pain for which COX-2 drugs and nonspecific NSAIDs do not provide substantial relief, opioid medications, such as oxycodone and morphine, are recommended
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025